Mary Katharine Collins

Title: The Innovative Contributions of Mary Katharine Collins

Introduction

Mary Katharine Collins is a prominent inventor based in London, GB. She has made significant contributions to the field of biotechnology, particularly in the delivery of nucleic acids and retroviral vectors. With a total of 4 patents to her name, Collins has established herself as a key figure in her area of expertise.

Latest Patents

One of her latest patents focuses on the delivery of nucleic acids. This invention relates to a recombinant viral particle capable of delivering a nucleic acid to mammalian cells. The particle includes a member of a first specific binding pair that binds to a first receptor expressed on the surface of a cell, causing infection. Additionally, it features a surface-exposed member of a second specific binding pair that binds to a second receptor generally not expressed on the cell's surface. This binding inhibits infection of the cell by the viral particle. Another notable patent involves retroviral vectors produced by cell lines resistant to lysis by human serum. These retroviral vectors are particularly useful as in vivo gene delivery vehicles.

Career Highlights

Throughout her career, Collins has worked with esteemed organizations such as the Medical Research Council and Genetic Therapy, Inc. Her work has significantly advanced the understanding and application of gene delivery systems.

Collaborations

Collins has collaborated with notable individuals in her field, including Francois-Loic Cosset and Robin Anthony Weiss. These partnerships have further enriched her research and innovations.

Conclusion

Mary Katharine Collins is a trailblazer in the field of biotechnology, with her innovative patents paving the way for advancements in gene delivery systems. Her contributions continue to impact the scientific community and beyond.